Updates on COVID-19 (including visitor restrictions and mask requirements), monkeypox and flu. See Communicable Disease Updates

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.


Observational study on the use of robotic-assisted bronchoscopy

Trial ID:
Samir Makani, MD
The goal of this study is to collect data on the safety and diagnostic accuracy of the FDA approved Monarch robotic-assisted bronchoscopy platform in routine clinical practice.

Inclusion Criteria

Patients must:
  • Be over 21 years of age;
  • Be an acceptable candidate for an elective, non-emergent bronchoscopic procedure;
  • Have lung lesions 8 mm to 50 mm in size

Exclusion Criteria

Patients must not:
  • Have a medical contraindication to bronchoscopy as assessed by the investigator
  • Have uncorrectable bleeding disorders
  • Have medical devices interfering with electro-magnetic navigation, including but not limited to pacemaker
  • Be pregnant or nursing at the time of the procedure

Additional Info

  • Patients will undergo bronchoscopy with biopsy using the Monarch Robotic platform according to standard clinical care. Information will then be collected from medical records for research purposes.

Contact Info:

  • Laura Peluso, Manager of Interventional Pulmonology
  • Peluso.laura@scrippshealth.org
  • 760-487-0363